• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:矫春丽,宋艳芹,杜源,卢永颖,张雷明.双去甲氧基姜黄素对四氯化碳致小鼠急性肝损伤的保护作用及机制[J].药学研究,2019,38(5):253-256,294[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3266次   下载 3169次 本文二维码信息
码上扫一扫!
双去甲氧基姜黄素对四氯化碳致小鼠急性肝损伤的保护作用及机制
矫春丽1,2,宋艳芹2,杜源1,卢永颖1,张雷明1
字体:加大+|默认|缩小-
(1.烟台大学药学院,山东 烟台 264005;2.烟台市食品药品检验检测中心,山东 烟台 264000)
摘要:
目的 研究双去甲氧基姜黄素(BDMC)对四氯化碳(CCl4)致小鼠肝损伤模型的保护作用及机制。方法 雄性KM小鼠随机分为对照组、模型组、联苯双酯100 mg·kg-1剂量(BDD100)组、双去甲氧基姜黄素12.5、25及50 mg·kg-1剂量组,每组12只。联苯双酯及双去甲氧基姜黄素灌胃给药,每天1次,连续给药7 d。末次给药1 h后,除对照组外,其余小鼠均采用腹腔注射2%四氯化碳橄榄油溶液制备小鼠肝损伤模型。造模24 h后,检测血清谷氨酸转氨酶(ALT)及天冬氨酸转氨酶(AST)水平;ELISA法检测血清肿瘤坏死因子α(TNF-α)及白细胞介素1β(IL-1β)水平;Western blot检测肝组织bax、bcl-2及cleaved caspase-3蛋白表达。结果 与对照组相比,模型组小鼠血清谷氨酸转氨酶、天冬氨酸转氨酶活力及肿瘤坏死因子α、白细胞介素1β水平均明显升高(P<0.01);肝组织bax/bcl-2及cleaved caspase-3表达明显升高(P<0.05,P<0.01)。与模型组相比,双去甲氧基姜黄素12.5、25 mg·kg-1剂量组小鼠血清谷氨酸转氨酶、天冬氨酸转氨酶活力及肿瘤坏死因子α、白细胞介素1β水平均明显降低(P<0.05,P<0.01);肝组织bax/bcl-2及cleaved caspase-3表达明显降低(P<0.05, P<0.01)。结论 双去甲氧基姜黄素对四氯化碳致小鼠肝损伤具有保护作用,其机制可能与抗炎及抗凋亡有关。
关键词:  双去甲氧基姜黄素  肝损伤  抗炎  抗凋亡
DOI:10.13506/j.cnki.jpr.2019.05.002
基金项目:山东省自然科学基金培养基金项目(No.ZR2017PH073)
The effect and mechanism of bisdemethoxycurcumin on carbon tetrachloride-induced acute liver injury in mice
JIAO Chunli,SONG Yanqin,DU Yuan,LU Yongying,ZHANG Leiming
(1.School of Pharmacy, Yantai University, Yantai 264005,China;2. Yantai Center for Food and Drug Control, Yantai 264000,China)
Abstract:
Objective To investigate the effect and the mechanism of bisdemethoxycurcumin (BDMC) in mice with acute liver injury induced by carbon tetrachloride (CCl4).Methods Male KM mice were divided into six groups: control (CON), model (MODEL), biphenyl dimethyl dicarboxylate 100 mg·kg-1(BDD100),BDMC12.5、25 and 50 mg·kg-1 groups,12 mice per group.After administration for 7 continuous days, once per day, acute liver injury mice model was established by 2% carbon tetrachloride (CCl4) intraperitoneally except CON group. After 24 h, the alanine transferase (ALT) and aspartate transferase (AST) activities in serum were detected, and the level of tumor necrosis factor-α (TNF-α) and interleukin 1β (IL-1β) in serum were analyzed by commercial enzyme linked immunosorbent assay kits.The expression of bax, bcl-2 and cleaved caspase-3 in liver were evaluated by western blot.Results Compared with the CON group, CCl4 significantly improved serum ALT and AST activities, enhanced the levels of TNF-α and IL-1β in serum (P<0.01), up-regulated the bax/bcl-2 and protein expression of cleaved caspase-3 in liver (P<0.05, P<0.01). Compared with the MODEL group, BDMC notably inhibited ALT and AST activities, decreased the level of TNF-α and IL-1β in serum (P<0.05,P<0.01), down-regulated the bax/bcl-2 and the expression of cleaved caspase-3 in liver tissue(P<0.05,P<0.01).Conclusion BDMC has a hepatoprotective effect on CCl4-induced liver injury in mice. The possible mechanism may be related to the anti-inflammation and anti-apoptosis.
Key words:  Bisdemethoxycurcumin  Liver injury  Anti-inflammation  Anti-apoptosis
今日访问量:2433    总访问量:55338849
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司